DENTSPLY SIRONA (NASDAQ:XRAY) Earns Neutral Rating from Piper Sandler

Piper Sandler reiterated their neutral rating on shares of DENTSPLY SIRONA (NASDAQ:XRAY - Free Report) in a report released on Friday, Benzinga reports. The brokerage currently has a $32.00 target price on the medical instruments supplier's stock, down from their prior target price of $35.00.

A number of other equities analysts have also recently weighed in on the company. Needham & Company LLC lowered their price target on DENTSPLY SIRONA from $42.00 to $36.00 and set a buy rating for the company in a report on Friday. Robert W. Baird lowered their target price on DENTSPLY SIRONA from $35.00 to $33.00 and set a neutral rating for the company in a report on Friday. Barrington Research restated an outperform rating and set a $41.00 target price on shares of DENTSPLY SIRONA in a report on Thursday, April 18th. SVB Leerink started coverage on DENTSPLY SIRONA in a report on Monday, February 26th. They set an outperform rating and a $42.00 target price for the company. Finally, StockNews.com upgraded DENTSPLY SIRONA from a hold rating to a buy rating in a report on Friday, January 19th. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to MarketBeat.com, the stock has an average rating of Moderate Buy and an average price target of $36.90.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY traded down $0.09 during mid-day trading on Friday, hitting $28.29. The stock had a trading volume of 4,506,596 shares, compared to its average volume of 3,342,785. The firm's 50 day moving average is $32.24 and its 200 day moving average is $32.73. DENTSPLY SIRONA has a twelve month low of $26.27 and a twelve month high of $41.65. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.38 and a quick ratio of 0.95. The stock has a market capitalization of $5.87 billion, a price-to-earnings ratio of -45.43, a PEG ratio of 1.22 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last issued its earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.42. The company had revenue of $953.00 million during the quarter, compared to analysts' expectations of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. The firm's quarterly revenue was down 2.6% on a year-over-year basis. During the same period in the prior year, the business earned $0.39 EPS. Equities research analysts forecast that DENTSPLY SIRONA will post 2.05 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were given a $0.16 dividend. The ex-dividend date was Wednesday, March 27th. This represents a $0.64 dividend on an annualized basis and a yield of 2.26%. This is a positive change from DENTSPLY SIRONA's previous quarterly dividend of $0.14. DENTSPLY SIRONA's dividend payout ratio (DPR) is currently -103.22%.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of hedge funds have recently bought and sold shares of the stock. Principal Securities Inc. acquired a new stake in shares of DENTSPLY SIRONA during the 4th quarter worth about $26,000. VisionPoint Advisory Group LLC grew its stake in DENTSPLY SIRONA by 104.2% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier's stock worth $26,000 after buying an additional 395 shares during the last quarter. Headlands Technologies LLC purchased a new position in DENTSPLY SIRONA during the 4th quarter worth approximately $30,000. Parkside Financial Bank & Trust grew its stake in DENTSPLY SIRONA by 33.3% during the 4th quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier's stock worth $42,000 after buying an additional 292 shares during the last quarter. Finally, Anchor Investment Management LLC purchased a new position in DENTSPLY SIRONA during the 4th quarter worth approximately $47,000. Institutional investors and hedge funds own 95.70% of the company's stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.